1.... INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. Research Methodology
1.2.1 Secondary Research
1.2.2 Data Analysis Framework
1.2.3 Market size estimation
1.2.4 Forecasting
1.2.5 Primary Research and Data Validation
2.... MARKET SNAPSHOT, 2019-2030 Million USD
2.1. MARKET SNAPSHOT
3.... PORTER’S FIVE FORCE MODEL ANALYSIS
4.... MARKET DYNAMICS
4.1. GROWTH DRIVERS
4.1.1 DRIVER 1
4.1.2 DRIVER 2
4.1.3 DRIVER 3
4.1.4 DRIVER 4
4.2. CHALLENGES
4.2.1 CHALLENGE 1
4.2.2 CHALLENGE 2
4.3. OPPORTUNITIES
4.3.1 OPPORTUNITY 1
4.3.2 OPPORTUNITY 2
5.... Global Cancer Vaccines Market, By Technology
5.1. Overview
5.2. Dendritic Cells (DC) Cancer Vaccines
5.2.1 Dendritic Cells (DC) Cancer Vaccines Market, By Region
5.2.1.1 North America Dendritic Cells (DC) Cancer Vaccines Market, By Country
5.2.1.2 Europe Dendritic Cells (DC) Cancer Vaccines Market, By Country
5.2.1.3 Asia-Pacific Dendritic Cells (DC) Cancer Vaccines Market, By Country
5.2.1.4 RoW Dendritic Cells (DC) Cancer Vaccines Market, By Country
5.3. Recombinant Cancer Vaccines
5.3.1 Recombinant Cancer Vaccines Market, By Region
5.3.1.1 North America Recombinant Cancer Vaccines Market, By Country
5.3.1.2 Europe Recombinant Cancer Vaccines Market, By Country
5.3.1.3 Asia-Pacific Recombinant Cancer Vaccines Market, By Country
5.3.1.4 RoW Recombinant Cancer Vaccines Market, By Country
5.4. Antigen/Adjuvent Cancer Vaccines
5.4.1 Antigen/Adjuvent Cancer Vaccines Market, By Region
5.4.1.1 North America Antigen/Adjuvent Cancer Vaccines Market, By Country
5.4.1.2 Europe Antigen/Adjuvent Cancer Vaccines Market, By Country
5.4.1.3 Asia-Pacific Antigen/Adjuvent Cancer Vaccines Market, By Country
5.4.1.4 RoW Antigen/Adjuvent Cancer Vaccines Market, By Country
5.5. Viral Vector and DNA Cancer Vaccines
5.5.1 Viral Vector and DNA Cancer Vaccines Market, By Region
5.5.1.1 North America Viral Vector and DNA Cancer Vaccines Market, By Country
5.5.1.2 Europe Viral Vector and DNA Cancer Vaccines Market, By Country
5.5.1.3 Asia-Pacific Viral Vector and DNA Cancer Vaccines Market, By Country
5.5.1.4 RoW Viral Vector and DNA Cancer Vaccines Market, By Country
6.... Global Cancer Vaccines Market, By Type
6.1. Overview
6.2. Preventive Cancer Vaccines
6.2.1 Preventive Cancer Vaccines Market, By Region
6.2.1.1 North America Preventive Cancer Vaccines Market, By Country
6.2.1.2 Europe Preventive Cancer Vaccines Market, By Country
6.2.1.3 Asia-Pacific Preventive Cancer Vaccines Market, By Country
6.2.1.4 RoW Preventive Cancer Vaccines Market, By Country
6.3. Therapeutic Cancer Vaccines
6.3.1 Therapeutic Cancer Vaccines Market, By Region
6.3.1.1 North America Therapeutic Cancer Vaccines Market, By Country
6.3.1.2 Europe Therapeutic Cancer Vaccines Market, By Country
6.3.1.3 Asia-Pacific Therapeutic Cancer Vaccines Market, By Country
6.3.1.4 RoW Therapeutic Cancer Vaccines Market, By Country
7.... Global Cancer Vaccines Market, By Indication
7.1. Overview
7.2. Cervical Cancer
7.2.1 Cervical Cancer Market, By Region
7.2.1.1 North America Cervical Cancer Market, By Country
7.2.1.2 Europe Cervical Cancer Market, By Country
7.2.1.3 Asia-Pacific Cervical Cancer Market, By Country
7.2.1.4 RoW Cervical Cancer Market, By Country
7.3. Prostate Cancer
7.3.1 Prostate Cancer Market, By Region
7.3.1.1 North America Prostate Cancer Market, By Country
7.3.1.2 Europe Prostate Cancer Market, By Country
7.3.1.3 Asia-Pacific Prostate Cancer Market, By Country
7.3.1.4 RoW Prostate Cancer Market, By Country
7.4. Other Indications
7.4.1 Other Indications Market, By Region
7.4.1.1 North America Other Indications Market, By Country
7.4.1.2 Europe Other Indications Market, By Country
7.4.1.3 Asia-Pacific Other Indications Market, By Country
7.4.1.4 RoW Other Indications Market, By Country
8.... Global Cancer Vaccines Market, By End User
8.1. Overview
8.2. Pediatrics
8.2.1 Pediatrics Market, By Region
8.2.1.1 North America Pediatrics Market, By Country
8.2.1.2 Europe Pediatrics Market, By Country
8.2.1.3 Asia-Pacific Pediatrics Market, By Country
8.2.1.4 RoW Pediatrics Market, By Country
8.3. Adults
8.3.1 Adults Market, By Region
8.3.1.1 North America Adults Market, By Country
8.3.1.2 Europe Adults Market, By Country
8.3.1.3 Asia-Pacific Adults Market, By Country
8.3.1.4 RoW Adults Market, By Country
9.... Global Cancer Vaccines Market, By Region
9.1. Overview
9.2. North America
9.2.1 North America Cancer Vaccines Market, By Technology
9.2.2 North America Cancer Vaccines Market, By Type
9.2.3 North America Cancer Vaccines Market, By Indication
9.2.4 North America Cancer Vaccines Market, By End User
9.2.5 North America Cancer Vaccines, Market By Country
9.2.5.1 U.S.
9.2.5.1.1 U.S. Cancer Vaccines Market, By Technology
9.2.5.1.2 U.S. Cancer Vaccines Market, By Type
9.2.5.1.3 U.S. Cancer Vaccines Market, By Indication
9.2.5.1.4 U.S. Cancer Vaccines Market, By End User
9.2.5.2 Canada
9.2.5.2.1 Canada Cancer Vaccines Market, By Technology
9.2.5.2.2 Canada Cancer Vaccines Market, By Type
9.2.5.2.3 Canada Cancer Vaccines Market, By Indication
9.2.5.2.4 Canada Cancer Vaccines Market, By End User
9.2.5.3 Mexico
9.2.5.3.1 Mexico Cancer Vaccines Market, By Technology
9.2.5.3.2 Mexico Cancer Vaccines Market, By Type
9.2.5.3.3 Mexico Cancer Vaccines Market, By Indication
9.2.5.3.4 Mexico Cancer Vaccines Market, By End User
9.3. Europe
9.3.1 Europe Cancer Vaccines Market, By Technology
9.3.2 Europe Cancer Vaccines Market, By Type
9.3.3 Europe Cancer Vaccines Market, By Indication
9.3.4 Europe Cancer Vaccines Market, By End User
9.3.5 Europe Cancer Vaccines, Market By Country
9.3.5.1 Germany
9.3.5.1.1 Germany Cancer Vaccines Market, By Technology
9.3.5.1.2 Germany Cancer Vaccines Market, By Type
9.3.5.1.3 Germany Cancer Vaccines Market, By Indication
9.3.5.1.4 Germany Cancer Vaccines Market, By End User
9.3.5.2 UK
9.3.5.2.1 UK Cancer Vaccines Market, By Technology
9.3.5.2.2 UK Cancer Vaccines Market, By Type
9.3.5.2.3 UK Cancer Vaccines Market, By Indication
9.3.5.2.4 UK Cancer Vaccines Market, By End User
9.3.5.3 France
9.3.5.3.1 France Cancer Vaccines Market, By Technology
9.3.5.3.2 France Cancer Vaccines Market, By Type
9.3.5.3.3 France Cancer Vaccines Market, By Indication
9.3.5.3.4 France Cancer Vaccines Market, By End User
9.3.5.4 Italy
9.3.5.4.1 Italy Cancer Vaccines Market, By Technology
9.3.5.4.2 Italy Cancer Vaccines Market, By Type
9.3.5.4.3 Italy Cancer Vaccines Market, By Indication
9.3.5.4.4 Italy Cancer Vaccines Market, By End User
9.3.5.5 Rest of Europe
9.3.5.5.1 Rest of Europe Cancer Vaccines Market, By Technology
9.3.5.5.2 Rest of Europe Cancer Vaccines Market, By Type
9.3.5.5.3 Rest of Europe Cancer Vaccines Market, By Indication
9.3.5.5.4 Rest of Europe Cancer Vaccines Market, By End User
9.4. Asia-Pacific
9.4.1 Asia-Pacific Cancer Vaccines Market, By Technology
9.4.2 Asia-Pacific Cancer Vaccines Market, By Type
9.4.3 Asia-Pacific Cancer Vaccines Market, By Indication
9.4.4 Asia-Pacific Cancer Vaccines Market, By End User
9.4.5 Asia-Pacific Cancer Vaccines, Market By Country
9.4.5.1 China
9.4.5.1.1 China Cancer Vaccines Market, By Technology
9.4.5.1.2 China Cancer Vaccines Market, By Type
9.4.5.1.3 China Cancer Vaccines Market, By Indication
9.4.5.1.4 China Cancer Vaccines Market, By End User
9.4.5.2 India
9.4.5.2.1 India Cancer Vaccines Market, By Technology
9.4.5.2.2 India Cancer Vaccines Market, By Type
9.4.5.2.3 India Cancer Vaccines Market, By Indication
9.4.5.2.4 India Cancer Vaccines Market, By End User
9.4.5.3 Japan
9.4.5.3.1 Japan Cancer Vaccines Market, By Technology
9.4.5.3.2 Japan Cancer Vaccines Market, By Type
9.4.5.3.3 Japan Cancer Vaccines Market, By Indication
9.4.5.3.4 Japan Cancer Vaccines Market, By End User
9.4.5.4 Australia
9.4.5.4.1 Australia Cancer Vaccines Market, By Technology
9.4.5.4.2 Australia Cancer Vaccines Market, By Type
9.4.5.4.3 Australia Cancer Vaccines Market, By Indication
9.4.5.4.4 Australia Cancer Vaccines Market, By End User
9.4.5.5 Rest of Asia-Pacific
9.4.5.5.1 Rest of Asia-Pacific Cancer Vaccines Market, By Technology
9.4.5.5.2 Rest of Asia-Pacific Cancer Vaccines Market, By Type
9.4.5.5.3 Rest of Asia-Pacific Cancer Vaccines Market, By Indication
9.4.5.5.4 Rest of Asia-Pacific Cancer Vaccines Market, By End User
9.5. RoW
9.5.1 RoW Cancer Vaccines Market, By Technology
9.5.2 RoW Cancer Vaccines Market, By Type
9.5.3 RoW Cancer Vaccines Market, By Indication
9.5.4 RoW Cancer Vaccines Market, By End User
9.5.5 RoW Cancer Vaccines, Market By Country
9.5.5.1 Brazil
9.5.5.1.1 Brazil Cancer Vaccines Market, By Technology
9.5.5.1.2 Brazil Cancer Vaccines Market, By Type
9.5.5.1.3 Brazil Cancer Vaccines Market, By Indication
9.5.5.1.4 Brazil Cancer Vaccines Market, By End User
9.5.5.2 Argentina
9.5.5.2.1 Argentina Cancer Vaccines Market, By Technology
9.5.5.2.2 Argentina Cancer Vaccines Market, By Type
9.5.5.2.3 Argentina Cancer Vaccines Market, By Indication
9.5.5.2.4 Argentina Cancer Vaccines Market, By End User
9.5.5.3 Turkey
9.5.5.3.1 Turkey Cancer Vaccines Market, By Technology
9.5.5.3.2 Turkey Cancer Vaccines Market, By Type
9.5.5.3.3 Turkey Cancer Vaccines Market, By Indication
9.5.5.3.4 Turkey Cancer Vaccines Market, By End User
9.5.5.4 South Africa
9.5.5.4.1 South Africa Cancer Vaccines Market, By Technology
9.5.5.4.2 South Africa Cancer Vaccines Market, By Type
9.5.5.4.3 South Africa Cancer Vaccines Market, By Indication
9.5.5.4.4 South Africa Cancer Vaccines Market, By End User
9.5.5.5 Rest of RoW
9.5.5.5.1 Rest of RoW Cancer Vaccines Market, By Technology
9.5.5.5.2 Rest of RoW Cancer Vaccines Market, By Type
9.5.5.5.3 Rest of RoW Cancer Vaccines Market, By Indication
9.5.5.5.4 Rest of RoW Cancer Vaccines Market, By End User
10.. COMPANY PROFILES
10.1. Advaxis Inc.
10.1.1 COMPANY OVERVIEW
10.1.2 COMPANY SNAPSHOT
10.1.3 OPERATING BUSINESS SEGMENTS
10.1.4 PRODUCT PORTFOLIO
10.1.5 BUSINESS PERFORMANCE
10.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT
10.2. Amgen Inc.
10.2.1 COMPANY OVERVIEW
10.2.2 COMPANY SNAPSHOT
10.2.3 OPERATING BUSINESS SEGMENTS
10.2.4 PRODUCT PORTFOLIO
10.2.5 BUSINESS PERFORMANCE
10.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT
10.3. Dynavax Technologies Corporation
10.3.1 COMPANY OVERVIEW
10.3.2 COMPANY SNAPSHOT
10.3.3 OPERATING BUSINESS SEGMENTS
10.3.4 PRODUCT PORTFOLIO
10.3.5 BUSINESS PERFORMANCE
10.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT
10.4. Generex Biotechnology Corporation
10.4.1 COMPANY OVERVIEW
10.4.2 COMPANY SNAPSHOT
10.4.3 OPERATING BUSINESS SEGMENTS
10.4.4 PRODUCT PORTFOLIO
10.4.5 BUSINESS PERFORMANCE
10.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT
10.5. GlaxoSmithKline plc (GSK)
10.5.1 COMPANY OVERVIEW
10.5.2 COMPANY SNAPSHOT
10.5.3 OPERATING BUSINESS SEGMENTS
10.5.4 PRODUCT PORTFOLIO
10.5.5 BUSINESS PERFORMANCE
10.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT
10.6. Immunocellular Therapeutics, Ltd
10.6.1 COMPANY OVERVIEW
10.6.2 COMPANY SNAPSHOT
10.6.3 OPERATING BUSINESS SEGMENTS
10.6.4 PRODUCT PORTFOLIO
10.6.5 BUSINESS PERFORMANCE
10.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT
10.7. Merck & Co., Inc.
10.7.1 COMPANY OVERVIEW
10.7.2 COMPANY SNAPSHOT
10.7.3 OPERATING BUSINESS SEGMENTS
10.7.4 PRODUCT PORTFOLIO
10.7.5 BUSINESS PERFORMANCE
10.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT
10.8. Sanpower Group Co. Ltd. (Dendereon Corporation)
10.8.1 COMPANY OVERVIEW
10.8.2 COMPANY SNAPSHOT
10.8.3 OPERATING BUSINESS SEGMENTS
10.8.4 PRODUCT PORTFOLIO
10.8.5 BUSINESS PERFORMANCE
10.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT
10.9. UbiVac
10.9.1 COMPANY OVERVIEW
10.9.2 COMPANY SNAPSHOT
10.9.3 OPERATING BUSINESS SEGMENTS
10.9.4 PRODUCT PORTFOLIO
10.9.5 BUSINESS PERFORMANCE
10.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT
10.10. Vaccinogen, Inc.
10.10.1 COMPANY OVERVIEW
10.10.2 COMPANY SNAPSHOT
10.10.3 OPERATING BUSINESS SEGMENTS
10.10.4 PRODUCT PORTFOLIO
10.10.5 BUSINESS PERFORMANCE
10.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT
TABLE 1. Global Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 2. Dendritic Cells (DC) Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
TABLE 3. North America Dendritic Cells (DC) Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 4. Europe Dendritic Cells (DC) Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 5. Asia-Pacific Dendritic Cells (DC) Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 6. RoW Dendritic Cells (DC) Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 7. Recombinant Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
TABLE 8. North America Recombinant Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 9. Europe Recombinant Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 10. Asia-Pacific Recombinant Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 11. RoW Recombinant Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 12. Antigen/Adjuvent Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
TABLE 13. North America Antigen/Adjuvent Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 14. Europe Antigen/Adjuvent Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 15. Asia-Pacific Antigen/Adjuvent Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 16. RoW Antigen/Adjuvent Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 17. Viral Vector and DNA Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
TABLE 18. North America Viral Vector and DNA Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 19. Europe Viral Vector and DNA Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 20. Asia-Pacific Viral Vector and DNA Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 21. RoW Viral Vector and DNA Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 22. Global Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 23. Preventive Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
TABLE 24. North America Preventive Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 25. Europe Preventive Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 26. Asia-Pacific Preventive Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 27. RoW Preventive Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 28. Therapeutic Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
TABLE 29. North America Therapeutic Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 30. Europe Therapeutic Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 31. Asia-Pacific Therapeutic Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 32. RoW Therapeutic Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
TABLE 33. Global Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 34. Cervical Cancer Market Value, By Region, 2019-2030, Million USD
TABLE 35. North America Cervical Cancer Market Value, By Country, 2019-2030, Million USD
TABLE 36. Europe Cervical Cancer Market Value, By Country, 2019-2030, Million USD
TABLE 37. Asia-Pacific Cervical Cancer Market Value, By Country, 2019-2030, Million USD
TABLE 38. RoW Cervical Cancer Market Value, By Country, 2019-2030, Million USD
TABLE 39. Prostate Cancer Market Value, By Region, 2019-2030, Million USD
TABLE 40. North America Prostate Cancer Market Value, By Country, 2019-2030, Million USD
TABLE 41. Europe Prostate Cancer Market Value, By Country, 2019-2030, Million USD
TABLE 42. Asia-Pacific Prostate Cancer Market Value, By Country, 2019-2030, Million USD
TABLE 43. RoW Prostate Cancer Market Value, By Country, 2019-2030, Million USD
TABLE 44. Other Indications Market Value, By Region, 2019-2030, Million USD
TABLE 45. North America Other Indications Market Value, By Country, 2019-2030, Million USD
TABLE 46. Europe Other Indications Market Value, By Country, 2019-2030, Million USD
TABLE 47. Asia-Pacific Other Indications Market Value, By Country, 2019-2030, Million USD
TABLE 48. RoW Other Indications Market Value, By Country, 2019-2030, Million USD
TABLE 49. Global Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 50. Pediatrics Market Value, By Region, 2019-2030, Million USD
TABLE 51. North America Pediatrics Market Value, By Country, 2019-2030, Million USD
TABLE 52. Europe Pediatrics Market Value, By Country, 2019-2030, Million USD
TABLE 53. Asia-Pacific Pediatrics Market Value, By Country, 2019-2030, Million USD
TABLE 54. RoW Pediatrics Market Value, By Country, 2019-2030, Million USD
TABLE 55. Adults Market Value, By Region, 2019-2030, Million USD
TABLE 56. North America Adults Market Value, By Country, 2019-2030, Million USD
TABLE 57. Europe Adults Market Value, By Country, 2019-2030, Million USD
TABLE 58. Asia-Pacific Adults Market Value, By Country, 2019-2030, Million USD
TABLE 59. RoW Adults Market Value, By Country, 2019-2030, Million USD
TABLE 60. Global Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
TABLE 61. North America Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 62. North America Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 63. North America Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 64. North America Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 65. U.S. Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 66. U.S. Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 67. U.S. Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 68. U.S. Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 69. Canada Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 70. Canada Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 71. Canada Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 72. Canada Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 73. Mexico Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 74. Mexico Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 75. Mexico Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 76. Mexico Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 77. Europe Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 78. Europe Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 79. Europe Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 80. Europe Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 81. Germany Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 82. Germany Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 83. Germany Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 84. Germany Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 85. UK Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 86. UK Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 87. UK Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 88. UK Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 89. France Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 90. France Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 91. France Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 92. France Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 93. Italy Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 94. Italy Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 95. Italy Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 96. Italy Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 97. Rest of Europe Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 98. Rest of Europe Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 99. Rest of Europe Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 100. Rest of Europe Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 101. Asia-Pacific Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 102. Asia-Pacific Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 103. Asia-Pacific Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 104. Asia-Pacific Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 105. China Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 106. China Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 107. China Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 108. China Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 109. India Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 110. India Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 111. India Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 112. India Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 113. Japan Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 114. Japan Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 115. Japan Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 116. Japan Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 117. Australia Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 118. Australia Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 119. Australia Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 120. Australia Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 121. Rest of Asia-Pacific Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 122. Rest of Asia-Pacific Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 123. Rest of Asia-Pacific Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 124. Rest of Asia-Pacific Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 125. RoW Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 126. RoW Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 127. RoW Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 128. RoW Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 129. Brazil Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 130. Brazil Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 131. Brazil Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 132. Brazil Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 133. Argentina Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 134. Argentina Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 135. Argentina Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 136. Argentina Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 137. Turkey Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 138. Turkey Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 139. Turkey Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 140. Turkey Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 141. South Africa Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 142. South Africa Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 143. South Africa Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 144. South Africa Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 145. Rest of RoW Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
TABLE 146. Rest of RoW Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
TABLE 147. Rest of RoW Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
TABLE 148. Rest of RoW Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
TABLE 149. Advaxis Inc.: COMPANY SNAPSHOT
TABLE 150. Advaxis Inc.: OPERATING SEGMENTS
TABLE 151. Advaxis Inc.: PRODUCT PORTFOLIO
TABLE 152. Advaxis Inc.: KEY STRATERGY
TABLE 153. Amgen Inc.: COMPANY SNAPSHOT
TABLE 154. Amgen Inc.: OPERATING SEGMENTS
TABLE 155. Amgen Inc.: PRODUCT PORTFOLIO
TABLE 156. Amgen Inc.: KEY STRATERGY
TABLE 157. Dynavax Technologies Corporation: COMPANY SNAPSHOT
TABLE 158. Dynavax Technologies Corporation: OPERATING SEGMENTS
TABLE 159. Dynavax Technologies Corporation: PRODUCT PORTFOLIO
TABLE 160. Dynavax Technologies Corporation: KEY STRATERGY
TABLE 161. Generex Biotechnology Corporation: COMPANY SNAPSHOT
TABLE 162. Generex Biotechnology Corporation: OPERATING SEGMENTS
TABLE 163. Generex Biotechnology Corporation: PRODUCT PORTFOLIO
TABLE 164. Generex Biotechnology Corporation: KEY STRATERGY
TABLE 165. GlaxoSmithKline plc (GSK): COMPANY SNAPSHOT
TABLE 166. GlaxoSmithKline plc (GSK): OPERATING SEGMENTS
TABLE 167. GlaxoSmithKline plc (GSK): PRODUCT PORTFOLIO
TABLE 168. GlaxoSmithKline plc (GSK): KEY STRATERGY
TABLE 169. Immunocellular Therapeutics, Ltd: COMPANY SNAPSHOT
TABLE 170. Immunocellular Therapeutics, Ltd: OPERATING SEGMENTS
TABLE 171. Immunocellular Therapeutics, Ltd: PRODUCT PORTFOLIO
TABLE 172. Immunocellular Therapeutics, Ltd: KEY STRATERGY
TABLE 173. Merck & Co., Inc.: COMPANY SNAPSHOT
TABLE 174. Merck & Co., Inc.: OPERATING SEGMENTS
TABLE 175. Merck & Co., Inc.: PRODUCT PORTFOLIO
TABLE 176. Merck & Co., Inc.: KEY STRATERGY
TABLE 177. Sanpower Group Co. Ltd. (Dendereon Corporation): COMPANY SNAPSHOT
TABLE 178. Sanpower Group Co. Ltd. (Dendereon Corporation): OPERATING SEGMENTS
TABLE 179. Sanpower Group Co. Ltd. (Dendereon Corporation): PRODUCT PORTFOLIO
TABLE 180. Sanpower Group Co. Ltd. (Dendereon Corporation): KEY STRATERGY
TABLE 181. UbiVac: COMPANY SNAPSHOT
TABLE 182. UbiVac: OPERATING SEGMENTS
TABLE 183. UbiVac: PRODUCT PORTFOLIO
TABLE 184. UbiVac: KEY STRATERGY
TABLE 185. Vaccinogen, Inc.: COMPANY SNAPSHOT
TABLE 186. Vaccinogen, Inc.: OPERATING SEGMENTS
TABLE 187. Vaccinogen, Inc.: PRODUCT PORTFOLIO
TABLE 188. Vaccinogen, Inc.: KEY STRATERGY
FIGURE 1. Global Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 2. Dendritic Cells (DC) Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
FIGURE 3. North America Dendritic Cells (DC) Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 4. Europe Dendritic Cells (DC) Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 5. Asia-Pacific Dendritic Cells (DC) Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 6. RoW Dendritic Cells (DC) Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 7. Recombinant Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
FIGURE 8. North America Recombinant Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 9. Europe Recombinant Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 10. Asia-Pacific Recombinant Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 11. RoW Recombinant Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 12. Antigen/Adjuvent Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
FIGURE 13. North America Antigen/Adjuvent Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 14. Europe Antigen/Adjuvent Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 15. Asia-Pacific Antigen/Adjuvent Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 16. RoW Antigen/Adjuvent Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 17. Viral Vector and DNA Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
FIGURE 18. North America Viral Vector and DNA Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 19. Europe Viral Vector and DNA Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 20. Asia-Pacific Viral Vector and DNA Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 21. RoW Viral Vector and DNA Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 22. Global Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 23. Preventive Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
FIGURE 24. North America Preventive Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 25. Europe Preventive Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 26. Asia-Pacific Preventive Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 27. RoW Preventive Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 28. Therapeutic Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
FIGURE 29. North America Therapeutic Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 30. Europe Therapeutic Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 31. Asia-Pacific Therapeutic Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 32. RoW Therapeutic Cancer Vaccines Market Value, By Country, 2019-2030, Million USD
FIGURE 33. Global Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 34. Cervical Cancer Market Value, By Region, 2019-2030, Million USD
FIGURE 35. North America Cervical Cancer Market Value, By Country, 2019-2030, Million USD
FIGURE 36. Europe Cervical Cancer Market Value, By Country, 2019-2030, Million USD
FIGURE 37. Asia-Pacific Cervical Cancer Market Value, By Country, 2019-2030, Million USD
FIGURE 38. RoW Cervical Cancer Market Value, By Country, 2019-2030, Million USD
FIGURE 39. Prostate Cancer Market Value, By Region, 2019-2030, Million USD
FIGURE 40. North America Prostate Cancer Market Value, By Country, 2019-2030, Million USD
FIGURE 41. Europe Prostate Cancer Market Value, By Country, 2019-2030, Million USD
FIGURE 42. Asia-Pacific Prostate Cancer Market Value, By Country, 2019-2030, Million USD
FIGURE 43. RoW Prostate Cancer Market Value, By Country, 2019-2030, Million USD
FIGURE 44. Other Indications Market Value, By Region, 2019-2030, Million USD
FIGURE 45. North America Other Indications Market Value, By Country, 2019-2030, Million USD
FIGURE 46. Europe Other Indications Market Value, By Country, 2019-2030, Million USD
FIGURE 47. Asia-Pacific Other Indications Market Value, By Country, 2019-2030, Million USD
FIGURE 48. RoW Other Indications Market Value, By Country, 2019-2030, Million USD
FIGURE 49. Global Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 50. Pediatrics Market Value, By Region, 2019-2030, Million USD
FIGURE 51. North America Pediatrics Market Value, By Country, 2019-2030, Million USD
FIGURE 52. Europe Pediatrics Market Value, By Country, 2019-2030, Million USD
FIGURE 53. Asia-Pacific Pediatrics Market Value, By Country, 2019-2030, Million USD
FIGURE 54. RoW Pediatrics Market Value, By Country, 2019-2030, Million USD
FIGURE 55. Adults Market Value, By Region, 2019-2030, Million USD
FIGURE 56. North America Adults Market Value, By Country, 2019-2030, Million USD
FIGURE 57. Europe Adults Market Value, By Country, 2019-2030, Million USD
FIGURE 58. Asia-Pacific Adults Market Value, By Country, 2019-2030, Million USD
FIGURE 59. RoW Adults Market Value, By Country, 2019-2030, Million USD
FIGURE 60. Global Cancer Vaccines Market Value, By Region, 2019-2030, Million USD
FIGURE 61. North America Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 62. North America Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 63. North America Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 64. North America Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 65. U.S. Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 66. U.S. Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 67. U.S. Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 68. U.S. Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 69. Canada Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 70. Canada Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 71. Canada Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 72. Canada Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 73. Mexico Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 74. Mexico Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 75. Mexico Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 76. Mexico Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 77. Europe Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 78. Europe Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 79. Europe Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 80. Europe Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 81. Germany Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 82. Germany Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 83. Germany Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 84. Germany Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 85. UK Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 86. UK Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 87. UK Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 88. UK Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 89. France Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 90. France Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 91. France Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 92. France Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 93. Italy Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 94. Italy Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 95. Italy Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 96. Italy Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 97. Rest of Europe Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 98. Rest of Europe Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 99. Rest of Europe Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 100. Rest of Europe Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 101. Asia-Pacific Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 102. Asia-Pacific Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 103. Asia-Pacific Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 104. Asia-Pacific Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 105. China Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 106. China Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 107. China Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 108. China Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 109. India Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 110. India Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 111. India Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 112. India Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 113. Japan Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 114. Japan Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 115. Japan Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 116. Japan Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 117. Australia Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 118. Australia Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 119. Australia Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 120. Australia Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 121. Rest of Asia-Pacific Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 122. Rest of Asia-Pacific Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 123. Rest of Asia-Pacific Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 124. Rest of Asia-Pacific Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 125. RoW Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 126. RoW Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 127. RoW Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 128. RoW Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 129. Brazil Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 130. Brazil Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 131. Brazil Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 132. Brazil Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 133. Argentina Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 134. Argentina Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 135. Argentina Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 136. Argentina Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 137. Turkey Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 138. Turkey Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 139. Turkey Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 140. Turkey Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 141. South Africa Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 142. South Africa Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 143. South Africa Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 144. South Africa Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 145. Rest of RoW Cancer Vaccines Market Value, By Technology, 2019-2030, Million USD
FIGURE 146. Rest of RoW Cancer Vaccines Market Value, By Type, 2019-2030, Million USD
FIGURE 147. Rest of RoW Cancer Vaccines Market Value, By Indication, 2019-2030, Million USD
FIGURE 148. Rest of RoW Cancer Vaccines Market Value, By End User, 2019-2030, Million USD
FIGURE 149. Advaxis Inc.: NET SALES,2017-2019
FIGURE 150. Amgen Inc.: NET SALES,2017-2019
FIGURE 151. Dynavax Technologies Corporation: NET SALES,2017-2019
FIGURE 152. Generex Biotechnology Corporation: NET SALES,2017-2019
FIGURE 153. GlaxoSmithKline plc (GSK): NET SALES,2017-2019
FIGURE 154. Immunocellular Therapeutics, Ltd: NET SALES,2017-2019
FIGURE 155. Merck & Co., Inc.: NET SALES,2017-2019
FIGURE 156. Sanpower Group Co. Ltd. (Dendereon Corporation): NET SALES,2017-2019
FIGURE 157. UbiVac: NET SALES,2017-2019
FIGURE 158. Vaccinogen, Inc.: NET SALES,2017-2019